DECIDER: prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients >60 years with acu (Q35640809)
Jump to navigation
Jump to search
scientific article published on 26 May 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | DECIDER: prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients >60 years with acu |
scientific article published on 26 May 2015 |
Statements
1 reference
DECIDER: prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients >60 years with acu (English)
1 reference
Konstanze Döhner
1 reference
Olga Grishina
1 reference
Claudia Schmoor
1 reference
Björn Hackanson
1 reference
Beate Lubrich
1 reference
Annette M May
1 reference
Caroline Cieslik
1 reference
Michael J Müller
1 reference
Michael Lübbert
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference